AbbVie to report Q3 2026 on October 30 with EPS estimate of $3.77
FROM THE WIRE · FINANCE.YAHOO.COM
AbbVie ABBV is set to report third-quarter 2026 earnings on Oct. 30, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's sales is pinned at $17.37 billion, while earnings per share (EPS) are estimated at $3.77. Both metrics indicate an increase…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralPreview of a large pharma quarterly report, with consensus 2026 estimates trending lower.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01AbbVie will report on October 30 before the market opens.
- 02Consensus EPS is $3.77 and sales are $17.37 billion.
- 03The 2026 EPS estimate has fallen from $14.05 to $13.95 over the past 30 days.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets